UNSPSC 51172020: Sincalide

Sincalide (INN) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas.

UNSPSC 51172020 Sincalide (Commodity) represents pharmaceutical testing and diagnostic products acquired by state and local health, corrections, and human services agencies. State and local governments procure sincalide—a cholecystokinin analog used in diagnostic imaging to assess gallbladder and pancreatic function—through both direct pharmaceutical supply contracts and integrated testing services that bundle the drug with specimen collection, laboratory analysis, and reporting. Issuing bodies include state health and human services commissions, county corrections and community supervision departments, and multistate cooperative purchasing alliances serving state agencies and local public facilities. Solicitations under this code span direct-to-manufacturer pharmaceutical procurement, generic drug supply agreements, and integrated diagnostic testing services.

Recent activity shows three distinct procurement models. Collin County Community Supervision and Corrections Department issued RFP 2026-327 (due July 23, 2026) for offender specimen collection and drug testing services with an estimated contract value of $600,000 over two years plus three optional one-year renewals, encompassing immunoassay screening, LC/MS/MS or GC/MS confirmation, and alternative testing methodologies at two sites in the Dallas-Fort Worth area. The Texas Health and Human Services Commission released Request for Information HHS0017013 (April 3, 2026) to gather vendor intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels, signaling state intent to reshape pharmaceutical procurement strategy. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and over-the-counter products distributed across participating state and local government facilities in Minnesota and Oregon, requiring vendors to supply through three authorized wholesalers and maintain cGMP and DSCSA compliance. Geographic concentration appears heaviest in Texas and the Upper Midwest multistate cooperative region, with activity spanning corrections, public health, and human services functions.